Waging War on Cancer with the Sword of Immunity

Slides:

Advertisements

Similar presentations

Waging War on Cancer with the Sword of Immunity Cell Volume 158, Issue 2, (July 2014) DOI: /j.cell Copyright © 2014 Terms and Conditions.

Advertisements

Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.

The Good Fat Cell Volume 147, Issue 7, (December 2011) DOI: /j.cell Copyright © 2011 Terms and Conditions Terms and Conditions.

Combined Mass Spectrometry Imaging and Top-down Microproteomics Reveals Evidence of a Hidden Proteome in Ovarian Cancer Vivian Delcourt, Julien Franck,

Alvin Y. Liu, Martine P. Roudier, Lawrence D. True

Jason Back, MD, Joshua Jeanty, Steve Landas, MD

Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer C.E. Henry, C. Emmanuel, N.

Cancer in the Wilderness

Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers Ivana Catacchio, Anna Scattone, Nicola.

Converting Cold into Hot Tumors by Combining Immunotherapies

Microbiology Select Cell Volume 142, Issue 1, (July 2010)

“Ring-Fencing” BRCA1 Tumor Suppressor Activity

Modeling Methuselah Cell Volume 154, Issue 1, (July 2013)

Volume 8, Issue 20, (October 1998)

Genomics: Think Global, Act Local

Histopathologic features (all images at ×10 magnification).

Hungry for Mechanism in Hippo Signaling

The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients Stephen J Elledge, Angelika Amon Cancer.

Organ Regeneration Cell Volume 146, Issue 1, (July 2011)

Tailor-Made Renal Cell Carcinoma Vaccines

“Ring-Fencing” BRCA1 Tumor Suppressor Activity

Marie-Madeleine Dolmans, M. D. , Ph. D. , Valérie Luyckx, M. D

Molecular Characterization of Human Skin Response to Diphencyprone at Peak and Resolution Phases: Therapeutic Insights Nicholas Gulati, Mayte Suárez-Fariñas,

Geographic distribution in situ of MSI and MSS colorectal cancer–infiltrating lymphocytes. Geographic distribution in situ of MSI and MSS colorectal cancer–infiltrating.

Volume 148, Issue 3, (February 2012)

Cancer and the Immune System

In This Issue Cell Volume 158, Issue 5, (August 2014)

Targeted Therapeutics

Select: The Many Faces of Cancer

Cell Death and Destruction

Volume 135, Issue 6, (December 2008)

Volume 136, Issue 1, (January 2009)

Volume 131, Issue 7, (December 2007)

Resurrection Cell Volume 162, Issue 2, (July 2015)

Osteopontin-Expressing Macrophages in Non-Small Cell Lung Cancer Predict Survival Yue Li, MD, Bing-sheng Sun, MD, PhD, Baoxiang Pei, MD, Chen-guang Li,

Volume 143, Issue 5, (November 2010)

Germinal Center Selection and the Antibody Response to Influenza

Volume 152, Issue 1, (January 2013)

On Viruses, Discovery, and Recognition

Volume 151, Issue 1, Pages (October 2018)

Volume 136, Issue 4, (February 2009)

Kiran Devisetty, MD, Joseph K. Salama, MD Journal of Thoracic Oncology

Volume 127, Issue 1, (October 2006)

D. Garrett Brown, June L. Round Cell

Volume 139, Issue 5, (November 2009)

Volume 130, Issue 6, (September 2007)

Volume 130, Issue 6, (September 2007)

Biological Code Breaking

“The Best-Laid Plans … Often go Awry …”

Volume 90, Issue 5, Pages (September 1997)

Mapping Cancer Origins

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.

Volume 143, Issue 6, (December 2010)

A Movie of RNA Polymerase II Transcription

Volume 148, Issue 4, (February 2012)

The Structure of Host-Pathogen Interactions

Releasing the Brakes on Cancer Immunotherapy

Volume 151, Issue 3, (October 2012)

Padmanee Sharma, James P. Allison Cell

Volume 163, Issue 4, (November 2015)

Volume 163, Issue 2, (October 2015)

Select: Symmetry Breaking

Two Tales (Tails) of SAMHD1 Destruction by Vpx

Cell Biology Select Cell Volume 130, Issue 3, (August 2007)

Volume 17, Issue 2, Pages (February 2010)

Intratumoral changes in critical lymphocyte populations and numbers after NKTR-214 treatment. Intratumoral changes in critical lymphocyte populations and.

Volume 134, Issue 6, (September 2008)

Immune Cell Infiltration May Be a Key Determinant of Long-Term Survival in Small Cell Lung Cancer Prasuna Muppa, M.B.B.S., Simone Barreto Siqueira Parrilha.

In This Issue Cell Volume 145, Issue 3, (April 2011)

Volume 148, Issue 1, (January 2012)

Presentation transcript:

Waging War on Cancer with the Sword of Immunity Cell Volume 158, Issue 2, (July 2014) DOI: 10.1016/j.cell.2014.07.006 Copyright © 2014 Terms and Conditions

CD8+ cytotoxic lymphocytes (red) interact with CD4+ Foxp3+ regulatory T cells (CD4 is shown as a green ring surrounding Foxp3 labeled blue in the nucleus). Images courtesy of Fabien Garçon. Cell 2014 158, DOI: (10.1016/j.cell.2014.07.006) Copyright © 2014 Terms and Conditions

FasL (brown) is expressed by endothelium of tumors (right) and is absent from normal tissues (left) in an ovarian cancer patient. Image courtesy of G. Motz. Cell 2014 158, DOI: (10.1016/j.cell.2014.07.006) Copyright © 2014 Terms and Conditions

Schematic representation (left) of the CSF-1R ECD dimer, and the overall structure of the CSF-1R ECD monomer complex with Fab fragment of RG7155 (right). Image courtesy of C. Ries. Cell 2014 158, DOI: (10.1016/j.cell.2014.07.006) Copyright © 2014 Terms and Conditions

Lung metastases in the patient prior (top) and 6 months after treatment (bottom). Image courtesy of S. Rosenberg. Cell 2014 158, DOI: (10.1016/j.cell.2014.07.006) Copyright © 2014 Terms and Conditions